Norbert Szentandrassy
Overview
Explore the profile of Norbert Szentandrassy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kovacs Z, Horvath B, Dienes C, Ovari J, Kiss D, Hezso T, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519160
Several ion currents in the mammalian ventricular myocardium are substantially regulated by the sympathetic nervous system via β-adrenergic receptor activation, including the slow delayed rectifier K current and the L-type...
2.
Kovacs Z, Ovari J, Dienes C, Magyar J, Banyasz T, Nanasi P, et al.
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338415
Text Correction [...].
3.
Horvath B, Kovacs Z, Dienes C, Barta Z, Ovari J, Szentandrassy N, et al.
Sci Rep
. 2024 May;
14(1):11241.
PMID: 38755246
Current density, the membrane current value divided by membrane capacitance (C), is widely used in cellular electrophysiology. Comparing current densities obtained in different cell populations assume that C and ion...
4.
Naveed M, Mohammed A, Topal L, Kovacs Z, Dienes C, Ovari J, et al.
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760824
The present study was designed to test the hypothesis that the selectivity of blocking the late Na current (I) over the peak Na current (I) is related to the fast...
5.
Horvath B, Kovacs Z, Dienes C, Ovari J, Szentandrassy N, Magyar J, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111317
Late sodium current (I) is an important inward current contributing to the plateau phase of the action potential (AP) in the mammalian heart. Although I is considered as a possible...
6.
Kovacs Z, Ovari J, Dienes C, Magyar J, Banyasz T, Nanasi P, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111245
ABT-333 (dasabuvir) is an antiviral agent used in hepatitis C treatment. The molecule, similarly to some inhibitors of hERG channels, responsible for the delayed rectifier potassium current (I), contains the...
7.
Raduly A, Toth A, Sarkany F, Horvath B, Szentandrassy N, Nanasi P, et al.
ESC Heart Fail
. 2023 Feb;
10(2):1326-1335.
PMID: 36722665
Aims: Heart failure with reduced ejection fraction (HFrEF) is a disease with high mortality and morbidity. Recent positive inotropic drug developments focused on cardiac myofilaments, that is, direct activators of...
8.
Raduly A, Sarkany F, Kovacs M, Bernat B, Juhasz B, Szilvassy Z, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613900
Recent cardiotropic drug developments have focused on cardiac myofilaments. Danicamtiv, the second direct myosin activator, has achieved encouraging results in preclinical and clinical studies, thus implicating its potential applicability in...
9.
Szentandrassy N, Magyar Z, Hevesi J, Banyasz T, Nanasi P, Almassy J
Int J Mol Sci
. 2022 Apr;
23(8).
PMID: 35457253
Cardiac diseases are the leading causes of death, with a growing number of cases worldwide, posing a challenge for both healthcare and research. Therefore, the most relevant aim of cardiac...
10.
Horvath B, Szentandrassy N, Dienes C, Kovacs Z, Nanasi P, Chen-Izu Y, et al.
Front Physiol
. 2022 Apr;
13:864002.
PMID: 35370800
The patch clamp technique underwent continual advancement and developed numerous variants in cardiac electrophysiology since its introduction in the late 1970s. In the beginning, the capability of the technique was...